nb1001
Peptideexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jun 15, 2020 (NCT04379856)
Timeline
Indications
Studied for
Mechanism of action
GLP1R agonist
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04988997 | Phase 2 | Jun 14, 2021 | 9 Meters Biopharma, Inc. |
| NCT04379856 | Phase 1/Phase 2 (Phase 2) | Jun 15, 2020 | 9 Meters Biopharma, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| 9 Meters Biopharma, Inc. | For profit | 2 | 2 | 1 | 2020 |
1 organizations
Page 1 / 1